Aquila Acquisition Corporation in relation to the resignation of Mr. Yao LING as an Chief Financial Officer with effect from 31 December 2022. The Board of Directors of the Company announced that Dr. ZHANG Xiangyu (Sean) has been appointed as Chief Financial Officer of the Company with effect from 1 January 2023. Dr. Zhang, aged 43, has more than 10 years of extensive working experience in private equity investment across consumption, enterprise services, TMT, energy and high-end manufacturing sectors.

Prior to assuming the role of Chief Financial Officer of the Company, Dr. Zhang has been a managing director at CMB International Capital Corporation Limited (CMBI), where Dr. Zhang was a key contributor to the launch of CMBI private equity funds, M&A funds and bridge funds. He served as investment committee member of multiple funds held under CMBI and Investment Director of the CMBI Telecom Fund, held under CMBI International Capital Holdings (Shenzhen) Corporation Ltd. Prior to joining CMBI, Dr. Zhang was a senior member of CITIC Goldstone Investment Ltd., a subsidiary of CITIC Securities Co. Ltd., where he was responsible for deal sourcing, industry research, due diligence and financial analysis.

Dr. Zhang holds Ph.D., Master and Bachelor degrees in Nuclear Science and Technology from Tsinghua University. He graduated from the MBA program of the Cheung Kong Graduate School of Business. Dr. Zhang is an officer (as defined under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong)) of CMB International Asset Management Limited (CMBI AM, a Promoter of the Company), and has been licensed by the Securities and Futures Commission of Hong Kong to carry out Type 4 (advising on securities) and Type 9 (asset management) regulated activities since 2019.